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Abstract
Objectives This scoping review collated evidence of the pharmaceutical care
needs of people with sensory loss (SL).
Methods Electronic databases were searched with no limit on year of publica-
tion: Medline (1946); Embase; Cinahl (1979); and Web of Science (1985).
Search terms included the following: pharmacy; sight/hearing/dual impairment.
Studies were included if they involved people with SL requiring pharmaceutical
care and/or pharmacists/pharmacy support staff providing pharmaceutical care
for people with SL. All study designs were eligible. This was a scoping review,
and as such, the quality of studies was not formally evaluated.
Key findings Eleven studies were included. People with SL had lower levels of
medication knowledge than their peers without SL. People with SL were identi-
fied as being at higher risk of iatrogenic harm than people without SL. Com-
munication was a barrier to the provision of pharmaceutical care for people
with hearing loss, with pharmacists relying on the provision of written infor-
mation. The prevalence of SL increases with age, yet only two studies included
older people. No studies involved family or carers of people with SL, people
with dual loss or people with SL receiving polypharmacy.
Conclusions There is a paucity of data regarding the pharmaceutical care needs
of people with SL. Unmet pharmaceutical care needs put people with SL at
increased risk of harm from their medicines. A detailed understanding of the
needs of people with SL is required which will inform future delivery of phar-
maceutical care for this vulnerable population.
Introduction
Sensory loss (SL) is typically used to describe loss of
vision and/or hearing. Common causes of visual loss
include the following: age-related macular degeneration,
uncorrected refractive errors, cataract and glaucoma.[1,2]
An estimated 285 million people live with visual loss
worldwide; 39 million people are blind, 246 million peo-
ple have low vision, and 82% of people who are blind
are aged 50 and above.[1] More than one in 20 people
worldwide have ‘disabling hearing loss’ defined as hear-
ing loss >40 dB in the better hearing ear in adults and
loss >30 dB in the better hearing ear in children.[3]
Hearing loss is caused by genetics, complications at
birth, infectious diseases, ototoxic medication, exposure
to excessive noise and ageing.[3] In the UK, 132 000
people live with dual SL and approximately 356 000
people live with hearing or visual loss.[4] By 2030, the
number of people living with dual SL is projected to rise
to 569 000[4] due to the ageing population; almost
three-quarters of people living with severe dual SI are
aged 70 and over.[4]
People with SL experience disparities in health and
functioning. People with dual SL have higher mortality
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rates compared with people without SL.[5] Older people
with SL are more likely to have experienced a fall, to have
broken a hip and are more likely to have had a stroke
than individuals without SL.[6] Furthermore, older indi-
viduals with dual SL have higher levels of anxiety and
depression[6] and lower levels of participation in social
activities than participants without SL.[6] Individuals with
hearing loss also have higher levels of depressive symp-
toms and lower levels of self-rated health than partici-
pants without hearing loss.[7]
Effective, accessible and timely pharmaceutical care is
of importance for people with SL, particularly those who
are older and receiving polypharmacy or complex medica-
tion regimens.[6] A study in the United States found that
participants with sight loss were three times more likely
to report difficulty managing their medicines than people
without sight loss. People with hearing loss were 1.6 times
more likely than older people without SL to report diffi-
culty managing their medicines. Furthermore, people with
dual SL were four times more likely to report difficulty
managing their medicines than people without SL.[6] The
‘My Voice’ telephone interview survey of ‘approximately’
1200 blind/partially sighted people (exact figure not speci-
fied) in the UK found that nine out of 10 registered blind
or partially sighted respondents reported that it was diffi-
cult or impossible to read details on medicines packag-
ing.[8] Despite facing these difficulties, the report
identified that 15% of blind/partially sighted people were
carers, 30% of whom collected or administered medicines
for the person they cared for.
The purpose of this scoping review was to identify and
synthesise the literature regarding the pharmaceutical care
needs of people with SL.
Methods
Search strategy
The following electronic databases were searched: Ovid
Medline; Ovid Embase; Ovid Amed; Ovid HMIC;
Cochrane library; Ebsco Cinahl; Ebsco Psych Info; Web of
Science; ProQuest Assia; ProQuest Public Health; Pro-
Quest Social Services Abstracts; ProQuest Sociological
Abstracts; DynaMed Plus; BMJ Best Practice; and Elsevier
Clinical Key. Search terms included the following: phar-
macy; sight impairment; hearing impairment; and dual
impairment. No limits were set on year of publication;
searches were conducted between November 2016 and
September 2017. (A full search strategy for Medline is
included in Figure S1.) Titles and abstracts were assessed
for relevance, and full texts of relevant articles were
retrieved. The reference lists of included texts were
searched.
Selection criteria
Publications were included if they contained empirical
data (both quantitative and qualitative) which involved
people with SL requiring pharmaceutical care and/or
pharmacists/pharmacy support staff providing pharma-
ceutical care for people with SL. All evaluative study
designs were included. Due to resource limitations, only
studies published in the English language were included.
Results
The number of articles identified from database search
was as follows: Amed: 188; Cinahl: 42; Embase: 3095;
HMIC: 57; Medline: 537; ProQuest: 13; PsycINFO: 72;
and Web of Science: 89. After title, abstract and reference
list searches, 11 studies were included, of which three
were conducted in the UK,[9–11] two in each of United
States[12,13] and Malaysia[14,15] and one was conducted in
Canada,[16] Saudi Arabia,[17] Japan[18] and Thailand.[19]
Three studies included people described as deaf/hard of
hearing/hearing-impaired,[12,14,18] and four studies
included participants with sight loss.[9,15,16,19] One study
included participants with ‘normal’ vision who used gog-
gles to simulate sight loss.[10] Two studies specifically
sought to recruit participants over the age of 65.[9,16]
None of the studies recruited participants with dual
impairment, and one study of people with sight loss[15]
excluded participants if they had ‘uncorrectable’ hearing
loss. Two studies included community pharmacists.[11,13]
A range of research designs was used. One study used a
case–control design[9] to explore medicines management
in older people with sight loss compared with age-
matched controls without sight loss. Five cross-sectional
studies were included,[11,13,15,17,19] three of which utilised
questionnaires that were administered face-to-face by
researchers as the participants had sight loss.[15,17,19] One
study used focus groups with deaf and hearing-impaired
participants,[12] whilst another used a pre-/post design to
test the effect of a 2-hour medical education lecture for
deaf and hearing-impaired participants.[13] Two experi-
mental studies compared the legibility of sample prescrip-
tion medication labels from community pharmacies
against the legibility of prototype labels, based on best
practice guidelines.[10,16] Given the heterogeneity of the
study designs, sample sizes varied (see Table S1 in Sup-
porting information which shows a summary of included
studies).
Sight loss
Seven studies explored the pharmaceutical care needs of
patients with sight loss. The most common challenges for
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patients with sight loss in the study conducted in Saudi
Arabia were identifying medicines (indicated by 75% of
participants), recognising medicine dosages (82%) and
identifying expiry dates (92%).[17] The study in Malaysia
identified that reported ease of use varied by dosage form,
with liquid preparations and ear/eye drops rated as the
most difficult to use.[15] Furthermore, the case–control
study in Northern Ireland found that 24% of older partici-
pants with sight loss had difficulties distinguishing between
medicines compared with none of the age-matched con-
trols.[9] Two studies from Thailand and Malaysia[15,19]
reported that participants managed their medicines solely
by memory to distinguish between medicines and dosages.
The study from Malaysia also found that 75% of partici-
pants with sight loss did not know the expiry date of their
medicines and 58% were unable to name their medication,
whilst 72% of participants did not know how to store their
medicines appropriately.[15] The study also found that 89%
of participants reported that they were unable to read pre-
scription labels completely.
A study comprising of two surveys of 200 community
and hospital pharmacy staff in England examined staff
awareness of the pharmaceutical care needs of people with
sight loss and resources used in practice.[11] Pharmacy
staff awareness of sight loss was poor; 98% and 91% of
participants across the two surveys thought labelling
medicines was ‘extremely’ or ‘very’ important; however,
55% of respondents in both surveys reported assuming
that patients could read labels. The majority of pharmacy
staff, 82% of respondents in the first survey and 67% in
the second survey, indicated that no routine service was
available for people with sight loss.[11]
Three studies identified the role that family members
or carers played in facilitating the pharmaceutical care of
people with SL.[9,17,19] One case–control study[9] found
that more older people with sight loss relied on daily help
to administer or organise their medicines than age-
matched controls without sight loss. Over half (52%) of
95 participants in the study from Saudi Arabia received
their medication instructions from friends or relatives,
and 46% of participants relied on others to use their
medicines.[17] Nearly half (46%) of these participants did
not consider the service that they received from their
pharmacist to be sufficient to enable them to use their
medicines in the correct way.[17] Furthermore, whilst the
majority (91%) of these participants used Braille, only
18% received Braille labels with their medicines.[17] The
study of 86 participants with sight loss in Thailand
reported that 97% of participants who received dispensed
medicines also received an ‘explanation of drug use’, but
the meaning of this statement was not clarified. Only
20% of participants received medicines package that
patients could differentiate by touch.[19]
The two studies which adopted an experimental
design, collected samples of pharmacy prescription medi-
cation labels and produced prototypes based on best
practice guidelines to assess and compare the effect on
the legibility of the labels.[10,16] The earlier study found
that none of the labels met the UK Design for Patient
Safety Guidelines[20] and that the median font size of
directions for using medicines was 9.5 point (range 8–
10) and not the recommended 12-point minimum font
size.[10] The study involved participants with ‘normal’
vision who wore goggles to simulate mild/moderate sight
loss; the prototype label increased accurate reading speed
by 58% compared with the typical pharmacy label in
the ‘mild’ sight loss category, whilst the large print label
increased accurate reading speed by 100%. In the simu-
lated ‘moderate’ sight loss condition, 65% of participants
were able to read the directions to use the medication
appropriately with the prototype label, increasing to 80%
of participants with a large print prototype label com-
pared with 20% of participants reading typical pharmacy
labels. The authors suggested that following the UK
Design for Patient Safety Guidelines increased legibility
for participants with simulated sight loss and recom-
mended that the study should be extended to partici-
pants with actual sight loss.[10]
The above study was then repeated in Canada[16] with
three groups of participants: 24 older adults with ‘normal’
vision; 24 older adults with sight loss; and 24 younger
adults with sight loss. No significant differences were
detected in participants’ reading speed and accuracy
between sample pharmacy labels and prototype labels or
between groups. However, prototype labels were read fas-
ter than sample pharmacy labels (p < 0.001) and partici-
pants preferred labels in the largest print option
(p < 0.001) and instructions with numbers written in
highlighted uppercase words (p < 0.001).
Hearing loss
Inadequate communication in the interaction between
pharmacists and people with hearing loss was identified
as a barrier to effective pharmaceutical care in four stud-
ies.[12,13,14,18] In a focus group study with 20 deaf/hear-
ing-impaired participants in the United States,
participants reported being unable to hear their name
being called out in the pharmacy and many struggled
with the complexity of written material given to them as
a means of communicating information about their medi-
cines.[12] Participants with hearing loss were unclear of
the roles and responsibilities of different members of the
pharmacy team and that their expectation of pharmacists
was to dispense medications rather than provide informa-
tion and support. Many participants reported that they
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were happy with the pharmacy service they received,
which they judged based on whether they received the
medicines they needed. However, several participants
reported that they felt pharmacy staff were rushed and
impatient. Many participants stated that they wanted
direct contact with the pharmacist and reported that the
lack of continuity amongst pharmacy staff members on
different visits made communication difficult.[12]
One study compared medication knowledge with par-
ticipants who were deaf or had hearing loss with partici-
pants who had no hearing loss. Participants who were
deaf had the lowest medication knowledge scores, and
participants with hearing loss also had lower medication
knowledge scores[18] In the same study, conducted in
Malaysia, deaf participants overestimated their knowledge
about their medicines.[18] The authors suggested that
pharmacists may not be providing deaf people with expla-
nations appropriate to their reading level.[18] One-third of
the 20 focus group study participants who were deaf/hard
of hearing in another study from Malaysia[14] had experi-
enced an adverse reaction to their medicines as a result of
not understanding how to use them. Many (40%) of the
participants were unaware that patients can experience
adverse effects if they do not understand instructions
given by a pharmacist.[14]
In a survey of 73 community pharmacists working in
an area with a large population of deaf people in the
United States, 36% of respondents indicated that deaf
patients received ‘less than their best care’ due to com-
munication issues.[13] Whilst 93% of pharmacists
reported previously interacting with a deaf patient, only
30% stated that they were somewhat/very comfortable
interacting with deaf patients.[13] The provision of writ-
ten information was the most commonly reported
method of communicating with deaf patients followed
by speaking so that the patient could lip read or use a
family member to interpret information. The authors
concluded that, whilst most pharmacists believed that
the provision of written information was a sufficient
method of communication, it might result in important
information being omitted due to time pressures and it
also does not ensure that the patient understands the
information. Similarly, the study conducted in Japan,
which involved a pharmacist-delivered ‘medical educa-
tion’ lecture to patients, also suggested that pharmacists
might not be providing deaf people with explanations
appropriate to their reading level[18]; finding that ‘medi-
cal education’ tailored to the reading skills of deaf par-
ticipants increased their knowledge of medicines.
However, in the study with 15 participants in Malaysia,
80% of participants selected written communication as a
means of accurately delivering messages; 66.7% selected
sign language, and 20% selected pictures.[14]
Pharmacists in the United States reported using
patients’ family members to communicate with patients
with hearing loss.[13]
Sensory loss and pharmaceutical care
Several studies identified that people with SL were at risk
of harm from their medicines.
Two studies found that people did not report their dif-
ficulties with medicines/SL to their pharmacist.[17,19]
A number of the studies made recommendations
intended to improve pharmaceutical care for people with
SL. One study reported participant recommendations for
improved pharmaceutical care for people with SL.[12] Par-
ticipants suggested communication between people with
hearing loss and pharmacy staff could be improved by the
following: larger writing on medicine labels; clearer warn-
ings; pharmacy staff using simpler language; printing out
information with pictures to highlight warnings and when
to use medicines; and that pharmacy staff used lists
instead of large paragraphs of information when written
information is provided. The suggestion of larger font
sizes on prescription labels was supported by the studies
comparing the legibility of sample pharmacy labels and
prototype labels based on best practice guidelines.[10,16]
The first study recommended that labels should be a min-
imum of font size 12,[10] whilst the second[16] recom-
mended a combination of larger print, consistent layout
and left justification; overall, lowercase lettering with
uppercase for numbers and instructions and highlighting
in yellow, noting that improvements in legibility of pre-
scription labels can be achieved without changing current
technology or label size.
Another study[17] also noted that pharmacists can use
rubber bands and tactile labels (dots or strips of tape)
to help people with sight loss differentiate between med-
icine containers. Authors of the case–control study of
older people with and without SL[9] highlighted the
importance of pharmacists asking patients about their
vision and ensuring that they have appropriate support
to open packaging, distinguish between medicines pack-
aging and use their medicines. This study listed exam-
ples of practical assistance included the following: the
use of large print labels; containers of different shapes
and textures; and electronic devices with prerecorded
instructions.[9]
It is of note that people with hearing loss who partici-
pated in the focus group study[12] did not expect pharma-
cists to become competent in sign language; rather they
wanted pharmacists to improve their knowledge of and
attitudes towards people with hearing loss, along with
improving their ability to interact with patients with hear-
ing loss. The study authors concluded that pharmacists
International Journal of Pharmacy Practice 2018, 26, pp. 380--386 © 2018 The Authors. International Journal of Pharmacy Practice
published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society
Kirsty Killick et al. 383
need training to become more culturally sensitive to the
deaf community and to become more competent in their
interactions with deaf patients. This conclusion was sup-
ported by another study[14] which suggested that training
pharmacists to be culturally competent is key to improv-
ing pharmaceutical services for people who are deaf or
experience hearing loss. Finally, the authors of the survey
of people with sight loss in Saudi Arabia recommended
change on a larger scale, calling for governments, pharma-
ceutical companies and pharmacists to work together to
meet the needs of people with sight loss.[17]
Discussion
This review included 11 studies, which met the inclusion
criteria, and highlighted a paucity of studies examining
the pharmaceutical care needs of people with SL and the
lack of evidence to inform practice. Overall, however,
there are clear indications that people with SL have more
problems managing their medicines than those without
SL, and thus, their pharmaceutical care should be tailored
to reflect this.
Strengths and limitations of the research
This study is the first to review and synthesise the pharma-
ceutical care needs of people with SL. Implications for
practice development, education and future research have
been identified. Given that this was not a systematic
review, the quality of the studies was not formally assessed.
This is consistent with scoping reviews as these include a
wide range of study designs.[21] It should be noted that the
sample sizes of a number of studies were small. Studies
were conducted in a variety of settings in various health-
care systems. The extant literature also does not reflect the
heterogeneous nature of SL. The pharmaceutical care
needs of people with dual SL were not explored in any of
the studies, and despite SL being most prevalent in older
people,[1,3,4] only two studies specifically investigated the
experiences of older people with SL. No study explored
the pharmaceutical care needs of people with SL using
polypharmacy. Only two studies explored the experiences
of pharmacy personnel when managing the pharmaceuti-
cal care needs of people with SL.
General discussion
The evidence suggests that people with SL are at increased
risk of harm from their medicines as a direct result of
their sensory impairment. People with sight loss encoun-
tered problems distinguishing and identifying medicines,
reading medicines labels and administering medi-
cine.[15,17,19] This is unsurprising; a study which
administered five tests relating to medicines management
to 492 community and residential setting dwelling older
people in Sweden found 9.4% of participants could not
read instructions on a medicine label.[22] This figure is
likely to be much higher in people with reported sight
loss. Furthermore, a study examining factors associated
with non-adherence to glaucoma medicines in 141 Ameri-
can veterans (mean age: 70.22) found that problems with
reading medicine instructions were one of three most
commonly reported difficulties.[23]
Communication was identified as a key barrier for both
pharmacists providing, and people with hearing loss
receiving, pharmaceutical care.[12,13,14,18] Pharmacists
reported relying on written information or on formal/in-
formal carers to communicate with people with SL. A
number of studies cited concern at the reliance on written
information as a means of communicating information
about medicines; suggesting that this does not ensure that
the patient has understood the information[13,18] and that
people who are deaf may have lower comprehension and
reading levels than people with no hearing loss.[18] Writ-
ten information also may not meet the communication
needs of people with dual SL.
Informal carers were identified as playing an impor-
tant role in facilitating the care of people with SI.[9,17]
Despite these findings, no studies of family members or
formal/informal carers were identified in the literature
searches for this review. It is important to understand
the experiences of carers who facilitate or have an active
role in medicines management for people with SI and to
identify whether they require support. A study in the
UK assessing the number and type of medicine-related
problems, and the impact this had on the health of peo-
ple caring for older people, was conducted.[24] Most
(67%) informal carers reported problems with at least
one medicine-related activity, and carers who reported a
greater number of medicine-related problems were more
likely to experience carer strain and poorer mental sta-
tus.[24] Furthermore, a literature review of 10 studies
investigating the perspective of informal carers facilitat-
ing medicines management in people with dementia
found that, amongst other dementia-specific difficulties,
carers reported that their role was made more challeng-
ing by complex medicines regimens, healthcare system
practices and a lack of information and/or training in
medicines management.[25]
Improving practice
From the limited evidence available, it appears that phar-
macy personnel and other providers of pharmaceutical
care do not have the appropriate knowledge and skills to
deliver safe and effective care to people with SL. Future
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research should seek to develop evidence-based training
to inform the pharmaceutical care of people with SL,
incorporating knowledge and understanding of the unique
issues people with SL face in relation to medicines man-
agement. It follows that incorporating the pharmaceutical
care needs of people with SI in undergraduate and post-
graduate pharmacy curricula is a potential means of
improving pharmaceutical care for this population. Fur-
thermore, it follows that all health professionals involved
in providing medicine-related care would benefit from
evidence-based training to inform their care of people
with SL.
Future research
Given the association between ageing and increased inci-
dence of SI,[1–4] future research is required to explore the
pharmaceutical care needs of older people with SL in
more detail. The current review identified only two stud-
ies which sought to recruit participants over the age of
65, one of which focussed specifically on the needs of
older people with SL. This is particularly important, as
rates of polypharmacy use also increase with age; older
people comprised 23% of the population in England in
2014, accounting for 60% of NHS prescriptions dis-
pensed.[26] Three-quarters of individuals ≥75 years use
prescribed medicines, and around 36% of older people
use ≥4 different medicines on a regular basis.[26]
Future research should consider the role formal/infor-
mal carers have in facilitating medicine management and
pharmaceutical care of people with SL. This review iden-
tified that pharmacists used carers to facilitate communi-
cation with patients with SL; however, no studies
exploring the role of carers in pharmaceutical care of
people with SL were identified. Finally, whilst a number
of studies made suggestions for pharmacists to facilitate
the pharmaceutical care of people with SI, however, only
one study asked participants with SL to suggest
improvements they would make to pharmaceutical care.
Only two studies explored the perspective of pharmacists
providing pharmaceutical care to people with SL. As our
review has highlighted, the literature focused on the
intersection of pharmaceutical care and SL is scarce. We
did not identify any intervention studies that sought to
enhance pharmaceutical care for people with SL. Future
research may specifically focus on strengthening the
communicative competencies of pharmacy personnel in
relation to people with SL. Further, we currently do not
know whether identified safety risks lead to preventable
medical complications, hospitalisations and mortality
amongst people with SL. Monitoring pharmaceutical
care-related health outcomes for this population is of
critical importance.
Conclusions
Despite the growing prevalence of sensory impairment
globally, there is a paucity of information regarding the
pharmaceutical care needs of people with sight, hearing
and dual SL.
This review presents a novel synthesis of existing evi-
dence and highlights that people with SL have addi-
tional pharmaceutical care needs (which vary according
to the nature of their impairment) that these needs are
not always met and that this patient population is at
increased risk of harm from their medication as a
result.
A detailed understanding of the needs of people with
SL is required which will inform future delivery of phar-
maceutical care for this vulnerable population.
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